Shrimp Disease Diagnostics Market - Global Forecast 2025-2032

Senior executives in global aquaculture are intensifying their focus on shrimp disease diagnostics, seeking actionable insights for health monitoring, biosecurity, and operational sustainability. As industry complexities grow, strategic investments in advanced diagnostics help mitigate risk, ensure compliance, and support decision-making across shrimp farming value chains.

Market Snapshot: Shrimp Disease Diagnostics Market Overview

The global shrimp disease diagnostics market is experiencing steady expansion, rising from USD 478.10 million in 2024 to USD 517.54 million in 2025. It is projected to maintain this momentum and reach USD 894.80 million by 2032, supported by a CAGR of 8.14%. This robust growth illustrates the sector’s acknowledgement of precise, scalable diagnostic platforms as core enablers in disease management. Increased biosecurity risks, an evolving regulatory backdrop, and accelerated deployment of high-throughput and onsite testing solutions are driving transformation. Aquaculture organizations are allocating capital to integrated and technology-driven solutions, prioritizing infrastructure that strengthens both disease prevention and operational efficiency.

Shrimp Disease Diagnostics Market: Scope & Segmentation

This report offers a detailed analysis of the shrimp disease diagnostics market structure, focusing on technologies, applications, end users, disease types, and regional presence. Understanding these segments is essential for leaders looking to optimize strategy and deploy targeted solutions.

• Technology: Enzyme Linked Immunosorbent Assay, Loop Mediated Isothermal Amplification, Next Generation Sequencing, Multiplex PCR, Quantitative PCR, and Reverse Transcription PCR support accurate, scalable pathogen detection and play a key role in diagnostics innovation.
• Diagnostic Method: Methods include Histopathological Diagnostics, Immunological Diagnostics such as Lateral Flow Immunoassay and Western Blot, and both Microbiological and Molecular Diagnostics, enabling diverse field and laboratory testing across health monitoring and outbreak investigation.
• Application: Solutions serve Monitoring, Outbreak Investigation, Research, and Screening, supporting routine surveillance and rapid response scenarios in farms and processing environments.
• End User: Academic Institutions, Aquaculture Farms, Diagnostic Laboratories, and Research Institutes use advanced diagnostics to enhance detection accuracy, influence research priorities, and improve overall animal health outcomes.
• Disease Type: Diagnostics are applied to Bacterial, Fungal, Parasitic, and Viral Diseases, offering targeted tools for disease control and reducing losses in production systems.
• Region: The market operates globally—covering the Americas, Europe, Middle East & Africa, and Asia-Pacific—with significant activity in countries like China, India, Brazil, and Vietnam where shrimp farming supports major economic sectors.
• Leading Companies: Thermo Fisher Scientific, Danaher Corporation, F. Hoffmann-La Roche, Abbott Laboratories, PerkinElmer, QIAGEN, Bio-Rad Laboratories, Zoetis, Merck, and Ceva Santé Animale are driving product innovation and reliable supply across regional value chains.

Shrimp Disease Diagnostics Market: Key Takeaways for Decision-Makers

• Advancements in molecular platforms and rapid diagnostics provide aquaculture producers with improved tools for early detection and timely risk response in disease management.
• Collaboration among research institutions, laboratories, and producers accelerates the adoption and standardization of new assays, enhancing sector-wide resilience and capacity building.
• Onsite diagnostic solutions, including portable isothermal amplification devices, increasingly benefit both large-scale and smallholder shrimp operations, reducing downtime and improving response efficiency.
• Integrated data management such as blockchain-enabled traceability supports greater transparency, allowing compliance with complex regulatory and export requirements.
• Regional strategies adapt to infrastructure, market demand, and local regulatory needs, supporting differentiated growth and fostering innovation tailored to diverse production environments.

Tariff Impact: Adjusting to US Regulatory Measures

Recent changes in US tariff regulations are impacting the cost structure for shrimp disease diagnostics. Increased expenses for testing consumables have prompted laboratories to adapt procurement processes, emphasizing the development of in-house reagents and fostering localized manufacturing partnerships. Greater collaboration between industry and academic stakeholders is enabling diagnostic labs to navigate these cost shifts and maintain the continuity of critical monitoring activities.

Methodology & Data Sources

This analysis combines interviews with key industry stakeholders, comprehensive reviews of scientific and policy sources, and data triangulation. Quantitative estimates are validated through proprietary shipment records, import-export information, and competitive benchmarking, ensuring rigorous, actionable intelligence for the shrimp disease diagnostics market.

Why This Report Matters to Industry Leaders

• Gain strategic direction on the adoption of advanced diagnostic technologies, implementation methods, and resource optimization within shrimp health management.
• Identify major regional trends and address procurement or compliance issues shaped by evolving regulatory and trade policies.
• Leverage market intelligence and comparative benchmarks to assess performance against leading global competitors.

Conclusion

This report equips industry leaders with precise, actionable intelligence to support risk mitigation, optimize investments, and guide the adoption of next-generation shrimp disease diagnostics in a dynamic global aquaculture landscape.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.